Abstract:Background: Methicillin-resistant Staphylococcus aureus (MRSA) is listed as a highly prioritized pathogen by the World Health Organization (WHO) to search for effective antimicrobial agents. Previously, we isolated a soil Brevibacillus sp. strain SPR19 from a botanical garden, which showed anti-MRSA activity. However, the active substances were still unknown. Methods: The cell-free supernatant of this bacterium was subjected to salt precipitation, cation exchange, and reversed-phase chromatography. The antimicrobial activity of pure substances was determined by broth microdilution assay. The peptide sequences and secondary structures were characterized by tandem mass spectroscopy and circular dichroism (CD), respectively. The most active anti-MRSA peptide underwent a stability study, and its mechanism was determined through scanning electron microscopy, cell permeability assay, time-killing kinetics, and biofilm inhibition and eradication. Hemolysis was used to evaluate the peptide toxicity. Results: The pure substances (BrSPR19-P1 to BrSPR19-P5) were identified as new peptides. Their minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) against S. aureus and MRSA isolates ranged from 2.00 to 32.00 and 2.00 to 64.00 µg/mL, respectively. The sequence analysis of anti-MRSA peptides revealed a length ranging from 12 to 16 residues accompanied by an amphipathic structure. The physicochemical properties of peptides were predicted such as pI (4.25 to 10.18), net charge at pH 7.4 (-3 to +4), and hydrophobicity (0.12 to 0.96). The CD spectra revealed that all peptides in the water mainly contained random coil structures. The increased proportion of α-helix structure was observed in P2-P5 when incubated with SDS. P2 (NH2-MFLVVKVLKYVV-COOH) showed the highest antimicrobial activity and high stability under stressed conditions such as temperatures up to 100 °C, solution of pH 3 to 10, and proteolytic enzymes. P2 disrupted the cell membrane and caused bacteriolysis, in which its action was dependent on the incubation time and peptide concentration. Antibiofilm activity of P2 was determined by which the half-maximal inhibition of biofilm formation was observed at 2.92 and 4.84 µg/mL for S. aureus TISTR 517 and MRSA isolate 2468, respectively. Biofilm eradication of tested pathogens was found at the P2 concentration of 128 µg/mL. Furthermore, P2 hemolytic activity was less than 10% at concentrations up to 64 µg/mL, which reflected the hemolysis index thresholds of 32. Conclusion: Five novel anti-MRSA peptides were identified from SPR19. P2 was the most active peptide and was demonstrated to cause membrane disruption and cell lysis. The P2 activity was dependent on the peptide concentration and exposure time. This peptide had antibiofilm activity against tested pathogens and was compatible with human erythrocytes, supporting its potential use as an anti-MRSA agent in this post-antibiotic era.

Antimicrobial Activity and Stability of the D-amino Acid Substituted Derivatives of Antimicrobial Peptide Polybia-Mpi.

D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP

The Effects of Incorporation of the Counterparts and Mimics of L-lysine on the Antimicrobial Activity, Hemolytic Activity, Cytotoxicity and Tryptic Stability of Antimicrobial Peptide Polybia-Mpii.

Intramolecular Cyclization of the Antimicrobial Peptide Polybia-MPI with Triazole Stapling: Influence on Stability and Bioactivity

Membrane Active Antimicrobial Activity and Molecular Dynamics Study of a Novel Cationic Antimicrobial Peptide Polybia-Mpi, from the Venom of Polybia Paulista

Tryptic Stability and Antimicrobial Activity of the Derivatives of Polybia-CP with Fine-Tuning Modification in the Side Chain of Lysine

Antitumor Effects, Cell Selectivity and Structure–activity Relationship of a Novel Antimicrobial Peptide Polybia-Mpi

D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics

Antimicrobial Activity, Membrane Interaction and Stability of the D-amino Acid Substituted Analogs of Antimicrobial Peptide W3R6.

Antimicrobial activity and stability of protonectin with D-amino acid substitutions.

A Novel Analog of Antimicrobial Peptide Polybia-MPI, with Thioamide Bond Substitution, Exhibits Increased Therapeutic Efficacy Against Cancer and Diminished Toxicity in Mice.

Effect Of Stereochemistry, Chain Length And Sequence Pattern On Antimicrobial Properties Of Short Synthetic Beta-Sheet Forming Peptide Amphiphiles

Design and Synthesis of New N-terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity.

Dual antifungal properties of cationic antimicrobial peptides polybia-MPI: Membrane integrity disruption and inhibition of biofilm formation

Design of Novel Antimicrobial Peptide Dimer Analogues with Enhanced Antimicrobial Activity in Vitro and in Vivo by Intermolecular Triazole Bridge Strategy.

Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity.

Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity

Study on the effects of different dimerization positions on biological activity of partial D-Amino acid substitution analogues of Anoplin

Engineering Enhanced Antimicrobial Properties in Α-Conotoxin RgIA Through D-Type Amino Acid Substitution and Incorporation of Lysine and Leucine Residues

Anti-methicillin-resistant Staphylococcus aureus and antibiofilm activity of new peptides produced by a Brevibacillus strain

Mechanism of Protease Resistance of D -Amino Acid Residue Containing Cationic Antimicrobial Heptapeptides